KLK3 and prostate cancer: The Chinese Prostate Cancer Consortium Risk Calculator (CPCC-RC) performed better in decision making of prostate biopsy in Chinese or in other Asian populations included PSA, PV, age, free PSA ration, and DRE but did not involve family history or prior biopsy [8].